Menu
GeneBe

UGDH

UDP-glucose 6-dehydrogenase

Basic information

Region (hg38): 4:39498754-39528311

Links

ENSG00000109814NCBI:7358OMIM:603370HGNC:12525Uniprot:O60701AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • developmental and epileptic encephalopathy, 84 (Strong), mode of inheritance: AR
  • developmental and epileptic encephalopathy, 84 (Strong), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Developmental and epileptic encephalopathy 84 (Jamuar syndrome)ARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingCraniofacial; Neurologic32001716

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the UGDH gene.

  • Epileptic encephalopathy (1 variants)
  • Developmental and epileptic encephalopathy, 84 (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the UGDH gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
7
clinvar
7
missense
3
clinvar
16
clinvar
1
clinvar
20
nonsense
1
clinvar
1
clinvar
2
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
1
1
1
3
non coding
0
Total 1 3 17 7 1

Highest pathogenic variant AF is 0.000112

Variants in UGDH

This is a list of pathogenic ClinVar variants found in the UGDH region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
4-39500188-C-G Likely benign (Feb 01, 2022)1675947
4-39500189-G-C Inborn genetic diseases Uncertain significance (Jan 24, 2023)2478392
4-39500205-G-A Inborn genetic diseases Uncertain significance (Nov 01, 2023)2285619
4-39500205-G-T Inborn genetic diseases Uncertain significance (Oct 26, 2023)3186038
4-39500207-G-A Inborn genetic diseases Uncertain significance (Sep 12, 2023)2622305
4-39500232-C-T Inborn genetic diseases Uncertain significance (Jul 06, 2021)2235431
4-39503903-T-C Epileptic encephalopathy Likely pathogenic (Oct 01, 2019)810641
4-39503921-C-T Epileptic encephalopathy Likely pathogenic (Oct 01, 2019)810642
4-39503925-G-A Epileptic encephalopathy Likely pathogenic (Oct 01, 2019)810643
4-39503957-T-C Inborn genetic diseases Uncertain significance (Dec 07, 2021)2265840
4-39503978-TC-T Inborn genetic diseases Pathogenic (Jun 04, 2024)3330806
4-39504452-C-A Epileptic encephalopathy Likely pathogenic (Oct 01, 2019)810644
4-39504503-G-A Epileptic encephalopathy • Developmental and epileptic encephalopathy, 84 Likely pathogenic (Feb 23, 2023)810645
4-39505308-T-C Epileptic encephalopathy • Developmental and epileptic encephalopathy, 84 Pathogenic/Likely pathogenic (Oct 07, 2020)810646
4-39505325-A-G Likely benign (Aug 01, 2023)2654730
4-39505340-A-C Epileptic encephalopathy Likely pathogenic (Oct 01, 2019)810647
4-39505377-G-GA Likely benign (Jul 01, 2024)1711589
4-39505705-C-T Epileptic encephalopathy • Developmental and epileptic encephalopathy, 84 Pathogenic/Likely pathogenic (Jan 03, 2022)592087
4-39505706-G-A Uncertain significance (Jun 15, 2022)1804342
4-39505728-G-C Developmental and epileptic encephalopathy, 84 Uncertain significance (Mar 14, 2024)3233379
4-39505734-A-G Likely benign (Jun 01, 2023)2654731
4-39505739-T-C Epileptic encephalopathy Likely pathogenic (Oct 01, 2019)810648
4-39505748-C-T Epileptic encephalopathy Likely pathogenic (Oct 01, 2019)810649
4-39509760-C-G Epileptic encephalopathy Likely pathogenic (Oct 01, 2019)810650
4-39509779-C-T Likely benign (Jul 01, 2024)1285104

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
UGDHprotein_codingprotein_codingENST00000316423 1129557
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.0006830.9961257080391257470.000155
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense2.301642710.6060.00001413247
Missense in Polyphen45120.060.37481479
Synonymous1.007890.10.8660.00000442945
Loss of Function2.53921.80.4149.84e-7290

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00006660.0000615
Ashkenazi Jewish0.000.00
East Asian0.00006450.0000544
Finnish0.00004680.0000462
European (Non-Finnish)0.0002590.000246
Middle Eastern0.00006450.0000544
South Asian0.0002620.000261
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Involved in the biosynthesis of glycosaminoglycans; hyaluronan, chondroitin sulfate, and heparan sulfate.;
Pathway
Ascorbate and aldarate metabolism - Homo sapiens (human);Amino sugar and nucleotide sugar metabolism - Homo sapiens (human);Pentose and glucuronate interconversions - Homo sapiens (human);Galactosemia III;Galactosemia II (GALK);Glycogen synthetase deficiency;Glycogenosis, Type III. Cori disease, Debrancher glycogenosis;Mucopolysaccharidosis VI. Sly syndrome;Sucrase-isomaltase deficiency;Glycogenosis, Type IV. Amylopectinosis, Anderson disease;Glycogenosis, Type VI. Hers disease;Starch and Sucrose Metabolism;Nucleotide Sugars Metabolism;Glucuronidation;Formation of the active cofactor, UDP-glucuronate;Glucuronidation;Phase II - Conjugation of compounds;UDP-D-xylose and UDP-D-glucuronate biosynthesis;Biological oxidations;Metabolism (Consensus)

Recessive Scores

pRec
0.110

Intolerance Scores

loftool
0.461
rvis_EVS
-0.14
rvis_percentile_EVS
43.57

Haploinsufficiency Scores

pHI
0.910
hipred
Y
hipred_score
0.614
ghis
0.538

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.976

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Ugdh
Phenotype
endocrine/exocrine gland phenotype; growth/size/body region phenotype; craniofacial phenotype; digestive/alimentary phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; embryo phenotype; vision/eye phenotype;

Zebrafish Information Network

Gene name
ugdh
Affected structure
atrioventricular valve
Phenotype tag
abnormal
Phenotype quality
aplastic

Gene ontology

Biological process
gastrulation with mouth forming second;UDP-glucose metabolic process;glycosaminoglycan biosynthetic process;UDP-glucuronate biosynthetic process;electron transport chain
Cellular component
nucleus;nucleoplasm;cytosol;extracellular exosome
Molecular function
UDP-glucose 6-dehydrogenase activity;electron transfer activity;NAD binding